Interview: Else Smith, Director General, CEO, The Danish Health and Medicines Authority
16.07.2013
Related Interviews
Jan van de Winkel – President & CEO, Genmab
Speaking exclusively to PharmaBoardroom, Jan van de Winkel highlights the tremendous progress that European biotech success story Genmab has made over the past six years, how its partnership model is…
Exclusive / GN Hearing CEO Gitte Aabo on Battling Hearing Aid Stigma & Digital Innovation
GN Hearing CEO Gitte Aabo highlights the significant unmet needs of hearing impairment patients, the role of private companies like GN in fighting against stigmas surrounding hearing aids, the digital…
Lars Georg Rust – Regional Managing Director North, Olympus
Lars Georg Rust outlines Olympus’ transition into fully-fledged MedTech company, the relevance of the Nordics and Netherlands to the global group, and some areas for improvement within the Danish hospital…
USA / Biden’s New FDA Pick Not Without Controversy
Almost ten months into his presidency, Joe Biden has announced his pick to lead the US Food and Drug Administration (FDA). If confirmed by the Senate, the nominee, Dr Robert…
China / Drug Approvals at Record High for 2020
The following is an overview from Accestra Consulting* of Part 2 of China’s Center for Drug Evaluation (CDE)’s 2020 reporting, including an overview of administrative drug approvals and fast track…
ASEAN / Regulatory Cooperation & Joint Assessments
Writing in the September edition of DIA’s Global Forum magazine, Rosilawati Ahmad of Malaysia’s National Pharmaceutical Regulatory Agency; Tharnkamol Chanprapaph of the Thai FDA; and Samvel Azatyan, Valerio Reggi, and…
Latest Report
